/
CDNA
$47.38+$0.07 (+0.15%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$2.4B
52M shares
52-week range
$11.27 – $49.76
94% from low
Sector
SERVICES-MEDICAL LABORATORIES
Exchange
NASDAQ
CS
Change$-23.87
CareDx, Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
www.caredx.com- Employees
- 765
- IPO / List date
- Jul 17, 2014
- HQ
- BRISBANE, CA
Held by traders on TradeandTell
No one on the platform currently holds CDNA.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 1,184,398 | $20.6M |
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded CDNA yet.
